Clinical trial
Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous…
NCT00155454 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00155454 |
|---|---|
| Title | Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy |
| Official title | Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Diabetic Retinopathy, Vitreous Hemorrhage |
| Intervention type | Procedure |
| Interventions | Intravitreal long acting gas (10% C3F8) |
| Enrollment | 61 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 27, 2012 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: